雷尔伟(301016) - 2022 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2022 was ¥111,279,794.85, a decrease of 21.45% compared to ¥141,661,329.57 in the same period last year[3] - Net profit attributable to shareholders was ¥20,444,934.28, down 46.27% from ¥38,052,314.10 year-on-year[3] - The basic earnings per share decreased by 59.52% to ¥0.17 from ¥0.42 in the previous year[3] - Operating profit for Q1 2022 was CNY 23,237,191.84, down 48.7% from CNY 45,061,706.41 in the previous year[22] - Net profit for Q1 2022 was CNY 20,444,934.28, representing a decline of 46.3% from CNY 38,052,314.10 in Q1 2021[23] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,100,895,195.51, an increase of 2.57% from ¥1,073,298,251.51 at the end of the previous year[3] - The total liabilities included accounts payable of CNY 94,817,966.59, down from CNY 101,224,695.48[18] - Total liabilities as of Q1 2022 were CNY 184,707,190.25, up from CNY 177,928,239.03 in the previous year[22] - The total cash and cash equivalents at the end of the period were ¥477,616,427.29, down from ¥56,707,442.00 year-over-year[26] Cash Flow - The company reported a net cash flow from operating activities of -¥48,015,748.68, a decline of 3.63% compared to -¥46,332,751.68 in the same period last year[3] - Cash flow from operating activities for Q1 2022 was negative CNY 48,015,748.68, slightly worse than negative CNY 46,332,751.68 in the same period last year[25] - The net cash flow from investment activities was -¥989,755.61, a decrease from -¥42,059,123.21 in the previous year[26] - The cash outflow from investment activities totaled ¥61,319,714.50, compared to ¥102,361,260.54 in the previous year[26] Research and Development - Research and development expenses rose by 33.97% to ¥6,203,223.45, reflecting increased investment in R&D projects[8] - Research and development expenses for Q1 2022 were CNY 6,203,223.45, an increase of 34% from CNY 4,630,370.65 in Q1 2021[22] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 11,930[11] - Total equity attributable to shareholders was CNY 916,188,005.26, an increase from CNY 895,370,012.48 in Q1 2021[22] Government Support - The company received government subsidies amounting to ¥781,625.00, which is a 762.48% increase compared to the previous year[9] Inventory and Accounts Receivable - Accounts receivable increased by 120.32% to ¥172,556,157.94, primarily due to sales made on credit[7] - Accounts receivable rose significantly to CNY 172,556,157.94, up from CNY 78,321,785.90, indicating a growth of approximately 104%[17] - The inventory level decreased to CNY 114,589,595.99 from CNY 135,283,529.74, reflecting a reduction of about 15%[17] Other Financial Metrics - The weighted average return on equity decreased to 9.03% from 36.48% year-on-year, a decline of 27.45%[3] - The company's cash and cash equivalents decreased to CNY 477,616,427.29 from CNY 526,547,793.46[17] - The company's fixed assets were valued at CNY 171,675,354.14, slightly down from CNY 174,662,254.36[18] - The total non-current assets were CNY 240,428,078.60, slightly down from CNY 240,569,619.90[18] Audit Status - The first quarter report was not audited[27]